シンバイオ製薬（4582）の空売り残高
シンバイオ製薬（4582）の現在の空売り残高は 2,859,647株、対発行株数の割合は 3.75% です（2026-06-16公表時点、4機関が報告）。
空売り残高（合計）の推移
- Barclays Capital Securities
- GOLDMAN SACHS
- JPM Securities Japan Co
- Nomura
- UBS
- モルガン・スタンレーMUFG証券
- Macquarie Bank
- Citigroup Global Markets
- MERRILL LYNCH
- JANE STREET GLOBAL TRADING
空売り者ごとの積み上げ（直近半年）。下の表は合計を最大12ヶ月分の数値で掲載。
繰越を反映した営業日ごとの空売り残高 合計（新しい順・直近90日を表示）。
| 計算日 | 残高数量（合計） | 残高割合 |
|---|---|---|
| 2026/04/30 | 2,897,880 | 3.88% (0.00%) |
| 2026/04/28 | 2,897,880 | 3.88% (-0.06%) |
| 2026/04/27 | 2,944,180 | 3.94% (-0.04%) |
| 2026/04/24 | 2,947,380 | 3.98% (-0.07%) |
| 2026/04/23 | 2,998,980 | 4.05% (+0.56%) |
| 2026/04/22 | 2,549,380 | 3.49% (+0.08%) |
| 2026/04/21 | 2,465,680 | 3.41% (+0.20%) |
| 2026/04/20 | 2,319,680 | 3.21% (-0.15%) |
| 2026/04/17 | 2,421,780 | 3.36% (-0.28%) |
| 2026/04/16 | 2,630,344 | 3.64% (-0.60%) |
| 2026/04/15 | 3,059,941 | 4.24% (-0.38%) |
| 2026/04/14 | 3,335,268 | 4.62% (-0.11%) |
| 2026/04/13 | 3,410,401 | 4.73% (+0.45%) |
| 2026/04/10 | 3,085,581 | 4.28% (-0.41%) |
| 2026/04/09 | 3,391,140 | 4.69% (-0.61%) |
| 2026/04/08 | 3,829,640 | 5.30% (-0.61%) |
| 2026/04/07 | 4,264,365 | 5.91% (0.00%) |
| 2026/04/06 | 4,264,365 | 5.91% (-0.27%) |
| 2026/04/03 | 4,462,603 | 6.18% (0.00%) |
| 2026/04/02 | 4,462,603 | 6.18% (-0.18%) |
| 2026/04/01 | 4,587,480 | 6.36% (-0.04%) |
| 2026/03/31 | 4,615,476 | 6.40% (-0.70%) |
| 2026/03/30 | 5,123,276 | 7.10% (-0.66%) |
| 2026/03/27 | 5,605,710 | 7.76% (-0.52%) |
| 2026/03/26 | 5,976,958 | 8.28% (+0.04%) |
| 2026/03/25 | 5,946,458 | 8.24% (-1.09%) |
| 2026/03/24 | 6,700,328 | 9.33% (-0.49%) |
| 2026/03/23 | 7,055,415 | 9.82% (-0.75%) |
| 2026/03/19 | 7,853,179 | 11.04% (-1.02%) |
| 2026/03/18 | 8,278,249 | 12.06% (-0.31%) |
機関別の空売り残高（過去12ヶ月の報告）
直近12ヶ月の機関別 空売り残高の報告（計算日の新しい順、全568件中 直近90件を表示）。
| 空売り者 | 計算日 | 残高数量 | 残高割合 |
|---|---|---|---|
| モルガン・スタンレーMUFG証券 | 4/6 | 631,427 | 0.87% (-0.03%) |
| Nomura | 4/2 | 1,615,921 | 2.24% (-0.14%) |
| GOLDMAN SACHS | 4/2 | 914,804 | 1.27% (-0.05%) |
| UBS | 4/2 | 433,600 | 0.60% (+0.01%) |
| Nomura | 4/1 | 1,715,098 | 2.38% (-0.11%) |
| GOLDMAN SACHS | 4/1 | 949,204 | 1.32% (+0.08%) |
| UBS | 4/1 | 424,900 | 0.59% (-0.01%) |
| GOLDMAN SACHS | 3/31 | 894,304 | 1.24% (+0.09%) |
| Macquarie Bank | 3/31 | 0 | 0.00% (-0.79%) |
| Nomura | 3/30 | 1,791,194 | 2.49% (-0.04%) |
| GOLDMAN SACHS | 3/30 | 830,604 | 1.15% (-0.14%) |
| UBS | 3/30 | 431,700 | 0.60% (+0.01%) |
| Nomura | 3/27 | 1,821,328 | 2.53% (-0.12%) |
| GOLDMAN SACHS | 3/27 | 932,604 | 1.29% (-0.20%) |
| Citigroup Global Markets | 3/27 | 357,400 | 0.49% (-0.20%) |
| モルガン・スタンレーMUFG証券 | 3/26 | 652,527 | 0.90% (+0.04%) |
| Nomura | 3/25 | 1,910,176 | 2.65% (-0.41%) |
| GOLDMAN SACHS | 3/25 | 1,074,204 | 1.49% (-0.09%) |
| モルガン・スタンレーMUFG証券 | 3/25 | 622,027 | 0.86% (-0.04%) |
| Citigroup Global Markets | 3/25 | 498,200 | 0.69% (-0.05%) |
| UBS | 3/25 | 424,600 | 0.59% (-0.04%) |
| Nomura | 3/24 | 2,199,642 | 3.06% (-0.21%) |
| Barclays Capital Securities | 3/24 | 335,304 | 0.46% (-0.28%) |
| Nomura | 3/23 | 2,354,729 | 3.27% (-0.18%) |
| JPM Securities Japan Co | 3/23 | 845,751 | 1.17% (-0.05%) |
| モルガン・スタンレーMUFG証券 | 3/23 | 652,627 | 0.90% (-0.11%) |
| Barclays Capital Securities | 3/23 | 535,304 | 0.74% (-0.41%) |
| Nomura | 3/19 | 2,482,294 | 3.45% (-0.46%) |
| GOLDMAN SACHS | 3/19 | 1,142,304 | 1.58% (-0.07%) |
| JPM Securities Japan Co | 3/19 | 879,451 | 1.22% (-0.13%) |